Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord mesenchymal stem cell exosomes for androgenetic alopecia in young men
ChiCTR2500109770Phase 2Not yet recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Sep 2025
- Modality
- Cell Therapies, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial of umbilical cord derived mesenchymal stem cells exosomes in androgenetic alopecia (AGA) (5 arms), sponsored by Shenzhen People's Hospital. Primary endpoints: Hair density, Hair diameter and 1 more. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
umbilical cord derived mesenchymal stem cells exosomes
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on ChiCTR2500109770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500109770.